Physician profile
Shamila Garg
NPI 1184663742
$3,348.27
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,325 · 2020: $191 · 2021: $57.40 · 2022: $459 · 2023: $1,175 · 2024: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $361.43 | 2019-2023 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $324.35 | 2019-2024 | |
| Janssen Biotech, INC. | $311.82 | 2019-2023 | |
| Genentech USA, INC. | $245.27 | 2019-2023 | Venclexta, Tecentriq, Avastin |
| E.R. Squibb & Sons, L.L.C. | $178.90 | 2019-2020 | |
| Lilly USA, LLC | $149.78 | 2019-2023 | Jaypirca, Retevmo, Verzenio |
| Celgene Corporation | $136.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $133.58 | 2019-2023 | Enhertu, Lynparza |
| Takeda Pharmaceuticals U.S.A., INC. | $131.64 | 2019-2023 | Ninlaro, Alunbrig |
| Seagen INC. | $101.97 | 2019-2023 | Padcev, Tukysa |
| Pharmacyclics LLC, An Abbvie Company | $100.54 | 2019-2022 | |
| Tempus Ai, INC | $100.00 | 2024 | |
| Amgen INC. | $97.85 | 2019-2023 | Lumakras |
| Ipsen Biopharmaceuticals, INC | $89.85 | 2019-2022 | |
| Eisai INC. | $86.86 | 2019-2023 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shamila Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.